Correction for Lancet Diabetes Endocrinol 2014; published online June 16

Corrections

Correction for Lancet Diabetes Endocrinol 2014; published online June 16 Ridderstråle M, Robert Andersen K, Zeller C, et al, on behalf of the EMPA-REG H2H-SU trial investigators. Comparison of empagliflozin and glimepiride as add-onto metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, doubleblind, phase 3 trial. Lancet Diabetes Endocrinol 2014; published online June 16. http://dx.doi.org/10.1016/ S2213-8587(14)70120-2—In this Article, in the fourth sentence of the second paragraph of the Results, the week number should have been 104 (not 24). This correction has been made to the online version as of July 9, 2014, and will be correct in the print version.

Published Online July 9, 2014 http://dx.doi.org/10.1016/ S2213-8587(14)70076-2

Correction for Lancet Diabetes Endocrinol 2014; 2: 573–80 Bolland MJ, Grey A, Gamble GD, Reid IR. Vitamin D supplementation and falls: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014; 2: 573–80—In figure 1 of this Article, the overall effect size (relative risk of falls with 95% CI) for vitamin D±calcium should have been 0·96 (0·91–1·01). This correction has been made to the online version as of Aug 5, 2014.

www.thelancet.com/diabetes-endocrinology Vol 2 September 2014

Published Online August 5, 2014 http://dx.doi.org/10.1016/ S2213-8587(14)70087-7

e15